February 1, 2011Cardiology in Review
Genetic Analysis in Cardiovascular Disease
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May guide precision CVD risk assessment; leaves open prospective trials before targeted therapy adoption.
Key Points
- To summarize current knowledge on the genetic architecture of both Mendelian and complex cardiovascular diseases and evaluate how genetic insights can refine clinical risk prediction and targeted therapies.
- Synthesized findings regarding single-gene Mendelian conditions, such as hypertrophic cardiomyopathy, alongside complex polygenic disorders, including coronary artery disease and hypertension.
- Evaluated methodological frameworks used to identify causal variants and examined strategies for integrating genetic testing into clinical risk assessment and disease-modifying care.
- Demonstrates that cardiovascular disease genetics spans high-penetrance single-gene mutations to complex polygenic networks influenced by shared family history.
- Highlights that incorporating genetic variant analysis refines individual risk calculation and establishes biological targets for tailored interventions to alter disease progression.
Cite This Study
Ho et al. (2011) studied this question.